Results 1 to 10 of about 269,054 (307)

Advances in Immunosuppressive Agents Based on Signal Pathway [PDF]

Frontiers in Pharmacology, 2022
Immune abnormality involves in various diseases, such as infection, allergic diseases, autoimmune diseases, as well as transplantation. Several signal pathways have been demonstrated to play a central role in the immune response, including JAK/STAT, NF ...
Zhiqing Xu, Zhiqing Xu, Ming Chu
doaj   +2 more sources

Failure of primary immunosuppressive agents in uveitis [PDF]

Indian Journal of Ophthalmology
Purpose: This retrospective study aimed to evaluate the effectiveness of various immunomodulatory therapy (IMT) regimens in managing non-infectious uveitis (NIU) and to identify optimal treatment strategies for refractory cases.
Ankush Kawali, Sara Rizvi, Sai Bhakti Mishra, Padmamalini Mahendradas, Rohit Shetty   +4 more
doaj   +2 more sources

Efficacy of Tripterygium glycosides in immune-mediated kidney diseases as a immunomodulation drug in combination with conventional immunosuppressive agents: a systematic review and meta-analysis of randomized controlled trials [PDF]

Frontiers in Pharmacology
BackgroundImmune-mediated kidney diseases involve the immune system attacking the kidneys, resulting in damage and dysfunction. Tripterygium glycosides (TG) are known for their strong immunosuppressive and anti-inflammatory effects and are commonly used ...
Yaotan Li, Yaotan Li, Jinyi Hou, Jinyi Hou, Xiaochang Wu, Xiaochang Wu, Chang Liu, Mengqi Zhou, Shijia Lin, Weijing Liu, Weijing Liu, Yaoxian Wang, Yaoxian Wang, Huijuan Zheng, Huijuan Zheng   +14 more
doaj   +2 more sources

Case report: Managing pemphigus foliaceus using apremilast without systemic glucocorticosteroids or immunosuppressive agents [PDF]

Frontiers in Immunology
Pemphigus foliaceus (PF) is a superficial form of pemphigus. Treatment options for PF resemble pemphigus vulgaris, including glucocorticosteroids, immunosuppressive agents and rituximab et al.
Quanhong Zhang, Quanhong Zhang, Lang Yu, Lang Yu, Li Wan, Liuqing Chen, Liuqing Chen, Jinbo Chen, Jinbo Chen   +8 more
doaj   +2 more sources

Acute psychotic disorder associated with immunosuppressive agent use after renal transplantation: a case report [PDF]

Psychiatry and Clinical Psychopharmacology, 2017
Kidney transplantation is the best treatment option for end-stage renal disease in appropriate patients. Immunosuppressant agents given in this duration can cause many psychiatric disorders.
Fulya Gok, Meliha Zengin Eroglu
doaj   +2 more sources

Efficacy and Safety of Glucocorticoid Monotherapy Versus the Combination of Glucocorticoid and Immunosuppressive Agents for Immunoglobulin G4-Related Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus, 2023
Alsalamah NI, Alhrabi B, Alhumaily N, AlHadidi R, Basubrain LS, Al Asmari Z.   +5 more
europepmc   +3 more sources

A fatal case of severe systemic varicella zoster infection in a patient with chronic use of immunosuppressive agents for cutaneous vasculitis

IDCases, 2020
Acute varicella zoster virus (VZV) infection is a common condition in children, which is considered a mild, self-limited disease with diffuse skin vesicular rash.
Wei-Chen Lin, Ching Chang, Meng-Cheng Ko, Shu-Min Lin   +3 more
doaj   +2 more sources

Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients. [PDF]

Expert Opin Drug Metab Toxicol, 2021
Job KM, Roberts JK, Enioutina EY, Illamola SM, Kumar SS, Rashid J, Ward RM, Fukuda T, Sherbotie J, Sherwin CM.   +9 more
europepmc   +3 more sources

Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis. [PDF]

Clin Exp Vaccine Res, 2023
Iryaningrum MR, Cahyadi A, Damara FA, Bandiara R, Marbun MBH.   +4 more
europepmc   +3 more sources

Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies? [PDF]

Cancer Cell Int
Anvar MT, Rashidan K, Arsam N, Rasouli-Saravani A, Yadegari H, Ahmadi A, Asgari Z, Vanan AG, Ghorbaninezhad F, Tahmasebi S.   +9 more
europepmc   +3 more sources